BRIAN REBER: Open Payments
NPI 1952338907 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,122 in 106 payments from 15 companies in 2025. Trend: 2023 $2,429 · 2024 $2,338 · 2025 $2,122
Food & beverage: $2,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $521 |
| Janssen Biotech, Inc. | 13 | $359 |
| GENZYME CORPORATION | 11 | $326 |
| LEO Pharma Inc. | 11 | $213 |
| Incyte Corporation | 8 | $197 |
| Galderma Laboratories, L.P. | 10 | $164 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| UCB, Inc. | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 1 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
Products named: RINVOQ, TREMFYA, DUPIXENT, OPZELURA, ADBRY, NEMLUVIO, AYVAKIT, SKYRIZI.
Industry payments across CA — which companies pay providers there.
